Patents-Review.com
ClassID:

21033 ⎘

A61K38/4826 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on peptide bonds (3.4); Serine endopeptidases (3.4.21) Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)

Recent Application in this class:
#1
20260016491
2026-01-15

METHODS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS

 #2
20250325012
2025-10-23

COMPOSITION CONTAINING DIGESTIVE ENZYMES AND NUTRIENTS SUITABLE FOR ENTERAL ADMINISTRATION

 #3
20250249083
2025-08-07

PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME

 #4
20250228896
2025-07-17

MATRIX BOUND NANOVESICLES ENCAPSULATED IN HYDROGELS

 #5
20250152678
2025-05-15

PROTEOLYTIC ENZYME COMPOSITION

 #6
20250134819
2025-05-01

ORAL DOSAGE FORM WITH A GASTRO RESISTANT CAPSULE SHELL

 #7
20240315972
2024-09-26

PROTEIN CONTAINING BIO-ACTIVE COMPOSITIONS COMPRISING CELLULOSE MICROPARTICLE CARRIERS

 #8
20240226249
2024-07-11

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

 #9
20240173387
2024-05-30

PEPTIDASE FORMULATION FOR TREATMENT OF MICROBIAL INFECTIONS IN THE UPPER RESPIRATORY TRACT

 #10
20240131125
2024-04-25

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

 #11
20240082367
2024-03-14

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

 #12
20230398067
2023-12-14

METAL-ORGANIC FRAMEWORK MEDIATED MACROMOLECULE DELIVERY SYSTEM

 #13
20230137573
2023-05-04

Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent

 #14
20230089740
2023-03-23

CANCER TREATMENT

 #15
20230056486
2023-02-23

METHODS OF TREATING NEUROLOGICAL DISORDERS

 #16
20230041686
2023-02-09

Method for Producing Peptide Ace Inhibitors

 #17
20220401528
2022-12-22

DENTAL PRETREATMENT MATERIAL AND DENTAL TISSUE REGENERATION KIT

 #18
20220362109
2022-11-17

Non-cellular root canal filler and non-cellular dental tissue regeneration promotion kit

 #19
20220347101
2022-11-03

ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATION AND USE

 #20
20220323554
2022-10-13

POLYSACCHARIDE-PEPTIDE COMPLEX FOR LOWERING BLOOD SUGAR, BLOOD LIPID AND GLYCOSYLATED HEMOGLOBIN LEVELS, AND PREPARATION METHOD

 #21
20220273733
2022-09-01

NUTRITIVE COMPOSITIONS WITH BIOACTIVE PROTEINS

 #22
20220257729
2022-08-18

COMBINATION OF INTEGRIN-TARGETING KNOTTIN-FC FUSION AND ANTI-CD47 ANTIBODY FOR THE TREATMENT OF CANCER

 #23
20220105161
2022-04-07

PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME

 #24
20220088151
2022-03-24

Proteolytic enzyme composition

 #25
20210353722
2021-11-18

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

 #26
20210340515
2021-11-04

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

 #27
20210316001
2021-10-14

Amino-reactive positively charged ATRP initiators that maintain their positive charge during synthesis of biomacro-initiators

 #28
20210299230
2021-09-30

Medicine for Covid-19 and treatment

 #29
20210270846
2021-09-02

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS

 #30
20210244801
2021-08-12

Enzymes Entrapped in Organopolysiloxane Matrix for Treating Intestinal Diseases

 #31
20210213112
2021-07-15

ESTERS OF HYDROXY-BENZOIC ACIDS FOR USE IN THE TREATMENT OF RHINOVIRUS

 #32
20210154276
2021-05-27

Methods of treating neurological disorders

 #33
20210145944
2021-05-20

Methods of treating neurological disorders

 #34
20210060142
2021-03-04

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

 #35
20200353060
2020-11-12

PEPTIDES HAVING PROTEASE ACTIVITY FOR USE IN THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION

 #36
20200323965
2020-10-15

COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS AND FOR THE ERADICATION OR REDUCTION OF STAPHYLOCOCCUS AUREUS ON SURFACES

 #37
20200323956
2020-10-15

Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin

 #38
20200323548
2020-10-15

HYALINE CARTILAGE SHAPING

 #39
20200282030
2020-09-10

Methods and Compositions for the Prevention and Treatment of Influenza

 #40
20200276280
2020-09-03

Antidotes for factor Xa inhibitors and methods of using the same

 #41
20200261321
2020-08-20

Non-cellular root canal filling material and non-cellular dental tissue regeneration promoting kit

 #42
20200246440
2020-08-06

DENTAL PRETREATMENT MATERIAL AND DENTAL TISSUE REGENERATION KIT

 #43
20200221748
2020-07-16

COMPOSITION CONTAINING DIGESTIVE ENZYMES AND NUTRIENTS SUITABLE FOR ENTERAL ADMINISTRATION

 #44
20200199175
2020-06-25

Method for synthesis of protein amphiphiles

 #45
20200179481
2020-06-11

Flounder surimi having antioxidant and antihypertensive effects and method of preparing the same

 #46
20200154702
2020-05-21

Stable Bioactive Substances and Methods of Making

 #47
20200129656
2020-04-30

ENZYMATIC WOUND DEBRIDING COMPOSITIONS WITH ENHANCED ENZYMATIC ACTIVITY

 #48
20200085921
2020-03-19

Combination therapies

 #49
20190388463
2019-12-26

Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent

 #50
20190382749
2019-12-19

Polymer engineered regenerating bioscavengers

 #51
20190382748
2019-12-19

Polymer engineered regenerating bioscavengers

 #52
20190358335
2019-11-28

STOMACH ACID-STABLE AND MUCIN-BINDING PROTEIN-POLYMER CONJUGATES

 #53
20190343932
2019-11-14

NOVEL TREATMENTS

 #54
20190309279
2019-10-10

Antidotes for factor Xa inhibitors and methods of using the same

 #55
20190282675
2019-09-19

Dental pretreatment material and dental tissue regeneration kit

 #56
20190262436
2019-08-29

Method for producing peptide ACE inhibitors

 #57
20190262435
2019-08-29

PROENZYME COMPOSITION

 #58
20190247473
2019-08-15

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

 #59
20190247471
2019-08-15

Pharmaceutical composition containing a mixture of proenzymes and enzymes

 #60
20190209667
2019-07-11

METHOD FOR DIAGNOSING AND TREATING DYSAUTONOMIA AND OTHER DYSAUTONOMIC CONDITIONS

 #61
20190201507
2019-07-04

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME

 #62
20190183989
2019-06-20

Use of serine protease inhibitors in the treatment of skin diseases

 #63
20190175704
2019-06-13

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #64
20190134212
2019-05-09

Supramolecular protein assemblies with advanced functions and synthesis thereof

 #65
20190134166
2019-05-09

Composition of proenzymes for cancer treatment

 #66
20190070300
2019-03-07

ZWITTERIONIC POLYMER BIOCONJUGATES AND RELATED METHODS

 #67
20190060509
2019-02-28

Enzymatic wound debriding compositions with enhanced enzymatic activity

 #68
20190060239
2019-02-28

Technology for the Preparation of Microparticles

 #69
20190038725
2019-02-07

Cancer treatment

 #70
20180360759
2018-12-20

Enzyme delivery systems and methods of preparation and use

 #71
20180296650
2018-10-18

Method for Treating Pervasive Development Disorders

 #72
20180280485
2018-10-04

THIORETINAMIDE COMPOSITIONS FOR THE APOPTOSIS OF MALIGNANT CELLS WHILE PREVENTING THE APOPTOSIS OF NORMAL CELLS AND RELATED METHODS

 #73
20180221444
2018-08-09

Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin

 #74
20180161409
2018-06-14

Method of diagnosing preeclampsia or pregnancy-induced hypertension

 #75
20180104315
2018-04-19

Compositions and methods for the treatment or the prevention of infections and for the eradication or reduction of surfaces

 #76
20180078623
2018-03-22

Methods and compositions for the treatment of symptoms of prion diseases

 #77
20180071375
2018-03-15

Methods and Compositions for the Treatment of Symptoms of Complex Regional Pain Syndrome

 #78
20180071374
2018-03-15

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #79
20180064753
2018-03-08

Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent

 #80
20180028449
2018-02-01

Technology for the Preparation of Microparticles

 #81
20170369546
2017-12-28

BMP peptides and methods of use

 #82
20170368152
2017-12-28

Enzyme formulation for reducing salicylate and other intolerance

 #83
20170354594
2017-12-14

PROTEASE COMPOSITIONS FOR USE IN MODIFYING SEMEN

 #84
20170246265
2017-08-31

PHARMACEUTICAL PREPARATIONS FOR ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND OTHER ASSOCIATED DISORDERS

 #85
20170233711
2017-08-17

Antidotes for factor Xa inhibitors and methods of using the same

 #86
20170231651
2017-08-17

Hyaline cartilage shaping

 #87
20170202934
2017-07-20

Methods and compositions for the prevention and treatment of influenza

 #88
20170165329
2017-06-15

Enzyme formulation for reducing salicylate intolerance

 #89
20170157221
2017-06-08

METHOD FOR TREATING PERVASIVE DEVELOPMENT DISORDERS

 #90
20170107503
2017-04-20

NOVEL METHODS, POLYPEPTIDES AND USES THEREOF

 #91
20170079920
2017-03-23

Technology for the Preparation of Microparticles

 #92
20170072029
2017-03-16

Enzymatic wound debriding compositions with enhanced enzymatic activity

 #93
20170028037
2017-02-02

Reduced-pressure treatment systems and methods employing debridement mechanisms

 #94
20170020996
2017-01-26

ENZYMATIC DEBRIDEMENT THERAPY FOR ABNORMAL CELL PROLIFERATION

 #95
20160375139
2016-12-29

Composition comprising a polymer and a bioactive agent and method of preparing thereof

 #96
20160354449
2016-12-08

Antidotes for factor Xa inhibitors and methods of using the same

 #97
20160339087
2016-11-24

NOVEL TREATMENTS

 #98
20160339085
2016-11-24

PHARMACEUTICAL COMPOSITION CONTAINING A MIXTURE OF PROENZYMES AND ENZYMES

 #99
20160310414
2016-10-27

MICROPARTICLES, BLOOD SUBSTITUTE AND METHOD FOR FORMING SAME

 #100
20160287683
2016-10-06

Method of treating proteinuria in pregnancy

 #101
20160263201
2016-09-15

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

 #102
20160244741
2016-08-25

Polymer engineered regenerating bioscavengers

 #103
20160235675
2016-08-18

Technology for the Preparation of Microparticles

 #104
20160206708
2016-07-21

Methods and compositions for the treatment of symptoms of Williams Syndrome

 #105
20160199465
2016-07-14

Compositions and method for utilization of thioretinamide in therapy of degenerative diseases of aging

 #106
20160101190
2016-04-14

Polymer-based protein engineering methods to rationally tune enzyme activity, pH-dependence and stability

 #107
20160095320
2016-04-07

Mixture to increase the effectiveness of antiseptics and/or disinfectants, an agent containing the mixture, and the use of this mixture

 #108
20160045576
2016-02-18

Enzyme delivery systems and methods of preparation and use

 #109
20160002617
2016-01-07

Antidotes for factor XA inhibitors and methods of using the same

 #110
20150359746
2015-12-17

Technology for the Preparation of Microparticles

 #111
20150335589
2015-11-26

Enzyme delivery systems and methods of preparation and use

 #112
20150273030
2015-10-01

Methods and compositions for the treatment of symptoms of prion diseases

 #113
20150246105
2015-09-03

Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces

 #114
20150246104
2015-09-03

Compositions and methods for the treatment or the prevention of infections and for the eradication or reduction of surfaces

 #115
20150174220
2015-06-25

Method of treating pregnancy-induced hypertension

 #116
20150174219
2015-06-25

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #117
20150157732
2015-06-11

Zwitterionic polymer bioconjugates and related methods

 #118
20150150955
2015-06-04

Enzyme delivery systems and methods of preparation and use

 #119
20150147401
2015-05-28

Controlled release of biological entities

 #120
20150064163
2015-03-05

BMP Peptides & Methods of Use

 #121
20150057228
2015-02-26

Antidotes for factor Xa inhibitors and methods of using the same

 #122
20150023944
2015-01-22

Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders

 #123
20140369993
2014-12-18

Stabilised protein compositions based on semifluorinated alkanes

 #124
20140341881
2014-11-20

USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES

 #125
20140271605
2014-09-18

STABLE BIOACTIVE SUBSTANCES AND METHODS OF MAKING

 #126
20140219954
2014-08-07

DRY POWDER FORMULATIONS OF ORGANIC MACROMOLECULES

 #127
20140170212
2014-06-19

Stable digestive enzyme compositions

 #128
20140161787
2014-06-12

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #129
20140079684
2014-03-20

Antidotes for factor Xa inhibitors and methods of using the same

 #130
20140044773
2014-02-13

Antidotes for factor XA inhibitors and methods of using the same

 #131
20140030333
2014-01-30

Method of treating toxemia

 #132
20140010788
2014-01-09

Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy

 #133
20130195833
2013-08-01

Methods and compositions for the treatment of symptoms of prion diseases

 #134
20130129693
2013-05-23

Antidotes for factor Xa inhibitors and methods of using the same

 #135
20130059001
2013-03-07

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #136
20130045279
2013-02-21

Analgesic and anti-inflammatory composition

 #137
20130045196
2013-02-21

Enzymatic wound debriding compositions with enhanced enzymatic activity

 #138
20120315239
2012-12-13

Zwitterionic polymer bioconjugates and related methods

 #139
20120269788
2012-10-25

Antidotes for factor Xa inhibitors and methods of using the same

 #140
20120258149
2012-10-11

Methods and compositions for the treatment of influenza

 #141
20120252090
2012-10-04

Heat resistant bioactive composition

 #142
20120251516
2012-10-04

Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent

 #143
20120230970
2012-09-13

Method for treating pervasive development disorders

 #144
20120220925
2012-08-30

Reduced-pressure treatment systems and methods employing debridement mechanisms

 #145
20120220924
2012-08-30

Reduced-pressure treatment systems and methods employing debridement mechanisms

 #146
20120207740
2012-08-16

Method for treating pervasive development disorders

 #147
20120197003
2012-08-02

Modified oligopeptides for the treatment of pancreatitis, stomach ulcers, and other hyperenzymemias based on enzyme peptide inhibitors and methods for obtaining them

 #148
20120189703
2012-07-26

Enzyme Delivery Systems and Methods of Preparation and Use

 #149
20120141590
2012-06-07

Technology for the Preparation of Microparticles

 #150
20120114626
2012-05-10

Method for treating pervasive development disorders

 #151
20120114562
2012-05-10

Method for treating pervasive development disorders

 #152
20120070504
2012-03-22

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #153
20120027848
2012-02-02

Enzyme delivery systems and methods of preparation and use

 #154
20120020947
2012-01-26

COMPOSITIONS AND METHODS FOR INCREASING LEAN MUSCLE MASS AFTER EXERCISE

 #155
20120020917
2012-01-26

Methods for accelerating wound healing by administration of a preadipocyte modulator or an adipocyte modulator

 #156
20110280854
2011-11-17

Compositions and methods for the treatment or the prevention of infections and for the eradication or reduction of surfaces

 #157
20110280853
2011-11-17

Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces

 #158
20110208162
2011-08-25

METHODS FOR PREVENTING AGGREGATION OF ADIPOSE STROMAL CELLS

 #159
20110182818
2011-07-28

Methods and compositions for the treatment of symptoms of neurological and mental health disorders

 #160
20110130338
2011-06-02

USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES

 #161
20110123634
2011-05-26

Stable digestive enzyme compositions

 #162
20110123633
2011-05-26

Stable digestive enzyme compositions

 #163
20110123605
2011-05-26

Stable digestive enzyme compositions

 #164
20110110905
2011-05-12

Infant Colic Supplement

 #165
20100331261
2010-12-30

Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome

 #166
20100330002
2010-12-30

COMPOSITIONS AND METHODS COMPRISING BASIC AMINO ACID PEPTIDES AND PROTEASES

 #167
20100297766
2010-11-25

Method of Removing Undesired Tissue from Connective Tissue

 #168
20100270183
2010-10-28

Stable digestive enzyme compositions

 #169
20100260857
2010-10-14

Enzyme delivery systems and methods of preparation and use

 #170
20100255000
2010-10-07

Antidotes for factor Xa inhibitors and methods of using the same

 #171
20100233218
2010-09-16

COMBINATION ENZYME FOR CYSTIC FIBROSIS

 #172
20100209518
2010-08-19

Micro-particles, blood-substitute and method for forming same

 #173
20100203034
2010-08-12

Methods for the treatment and prevention of diseases of biological conduits

 #174
20100160871
2010-06-24

Reduced-pressure treatment systems and methods employing debridement mechanisms

 #175
20100144625
2010-06-10

Organic Compounds

 #176
20100125052
2010-05-20

Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents

 #177
20100092447
2010-04-15

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES

 #178
20100080787
2010-04-01

COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN ENZYME WHICH IS INSOLUBLE IN AN AQUEOUS MEDIUM AS WELL AS ITS USES

 #179
20100055200
2010-03-04

Analgesic and anti-inflammatory composition

 #180
20100021537
2010-01-28

Stable digestive enzyme compositions

 #181
20100008898
2010-01-14

CHYMOTRYPSIN FROM LUCILIA SERICATA LARVAE AND ITS USE FOR THE TREATMENT OF WOUNDS

 #182
20090324730
2009-12-31

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME

 #183
20090324572
2009-12-31

Methods and compositions for the treatment of symptoms of Williams Syndrome

 #184
20090286270
2009-11-19

Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy

 #185
20090285790
2009-11-19

Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders

 #186
20090263372
2009-10-22

Method for the treatment of the symptoms of drug and alcohol addiction

 #187
20090252808
2009-10-08

Controlled release of biological entities

 #188
20090232789
2009-09-17

Compositions and use thereof for treating symptoms of preeclampsia

 #189
20090208474
2009-08-20

BIOLOGICAL ENTITIES AND THE USE THEREOF

 #190
20090208440
2009-08-20

BIOLOGICAL ENTITIES AND THE USE THEREOF

 #191
20090197289
2009-08-06

Method for identifying autistic individuals amenable to digestive enzyme therapy

 #192
20090130081
2009-05-21

Method for treating pervasive development disorders

 #193
20090098207
2009-04-16

Technology for the Preparation of Microparticles

 #194
20090098119
2009-04-16

Antidotes for factor Xa inhibitors and methods of using the same

 #195
20090081184
2009-03-26

NON-PANCREATIC PROTEASES FOR CONTROLLING PLASMA CHOLECYSTOKININ (CCK) CONCENTRATION AND FOR TREATING PAIN

 #196
20090010869
2009-01-08

Compositions for Topical Enzymatic Debridement

 #197
20080299185
2008-12-04

Stable digestive enzyme compositions

 #198
20080293117
2008-11-27

Heat resistant bioactive composition

 #199
20080286253
2008-11-20

Composition Comprising Polymeric Material And Uses Thereof

 #200
20080279953
2008-11-13

Methods of producing stable pancreatic enzyme compositions

 #201
20080274174
2008-11-06

Stable pancreatic enzyme compositions

 #202
20080219966
2008-09-11

Methods of treating pervasive development disorders

 #203
20080219951
2008-09-11

Stabilization of Biologically Active Proteins With Mixtures of Polysaccharides and Amino Acid Based Compounds

 #204
20080194485
2008-08-14

Detection and Use of Prolylcarboxypeptidase

 #205
20080166334
2008-07-10

COMBINATION ENZYME FOR CYSTIC FIBROSIS

 #206
20080159978
2008-07-03

Methods for accelerating wound healing by administration of adipokines

 #207
20080152637
2008-06-26

Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders

 #208
20080112945
2008-05-15

Synergistic compositions and methods for enhancing potency and/or for prolonging the duration of action of anesthetics

 #209
20080044459
2008-02-21

Enzymatic debridement therapy for abnormal cell proliferation

 #210
20080014169
2008-01-17

Compositions for Topical Enzymatic Debridement

 #211
20070212343
2007-09-13

COMPOSITIONS FOR TREATMENT OF EAR INFECTIONS

 #212
20070148153
2007-06-28

Delayed release pancreatin compositions

 #213
20070141042
2007-06-21

Methods for the treatment and prevention of diseases of biological conduits

 #214
20070116695
2007-05-24

PHARMACEUTICAL PREPARATIONS FOR ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND OTHER ASSOCIATED DISORDERS

 #215
20070053895
2007-03-08

METHOD OF TREATING AND DIAGNOSING PARKINSONS DISEASE AND RELATED DYSAUTONOMIC DISORDERS

 #216
20070048296
2007-03-01

Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation

 #217
20070031398
2007-02-08

One of several enzyme-containing compounds, dietetic food products and drugs produced from and the use therefor for medical purpose

 #218
20070003486
2007-01-04

Ointment wound spray

 #219
20060286086
2006-12-21

Lysozyme-based food stuff

 #220
20060198838
2006-09-07

Combination enzyme for cystic fibrosis

 #221
20060183180
2006-08-17

Methods for treating pervasive development disorders

 #222
20060182811
2006-08-17

Analgesic and anti-inflammatory composition

 #223
20060182728
2006-08-17

Methods for treating pervasive development disorders

 #224
20060177418
2006-08-10

Methods for accelerating wound healing by administration of adipokines

 #225
20060172949
2006-08-03

Compositions for preventing and treating digestive organs diseases

 #226
20060104944
2006-05-18

Activators and inhibitors of protease activated receptor2 (PAR2) and methods of use

 #227
20060083727
2006-04-20

Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation

 #228
20060024346
2006-02-02

Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds

 #229
20060019904
2006-01-26

Composition for promoting lacrimal secretion

 #230
20050281806
2005-12-22

Compositions for topical enzymatic debridement

 #231
20050255051
2005-11-17

Formulation for inhalation

 #232
20050244401
2005-11-03

Compositions and methods for reducing lung volume

 #233
20050175581
2005-08-11

Biological entities and the pharmaceutical and diagnostic use thereof

 #234
20050169886
2005-08-04

Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds

 #235
20050158299
2005-07-21

Treating abdominal pain due to pancreatitis with seaprose

 #236
20050152887
2005-07-14

Protonic formulation

 #237
20050059126
2005-03-17

Engineered enzymes and uses thereof

 #238
20050036950
2005-02-17

Ointment wound spray

 #239
20050025722
2005-02-03

Removing dental plaque with krill enzymes

 #240
20050002897
2005-01-06

Biological entities and the pharmaceutical or diagnostic use thereof

 #241
13067504
2015-12-22

Compositions and method for utilization of thioretinamide in therapy of degenerative diseases of aging